#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4418	16S	1529	1529	99.87	16S.l6.c30.ctg.1	2214	583.4	0	.	n	.	0	C451T	SNP	451	451	C	754	754	T	648	T	565	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4418	16S	1529	1529	99.87	16S.l6.c30.ctg.1	2214	583.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1753	1753	T	663	T,A	608,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4418	16S	1529	1529	99.87	16S.l6.c30.ctg.1	2214	583.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1487	1487	C	665	C,T,A	565,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4418	16S	1529	1529	99.87	16S.l6.c30.ctg.1	2214	583.4	0	HET	.	.	.	C466T	.	466	466	C	769	769	C	645	C,T	304,252	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	7588	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3757	604.3	0	.	n	.	0	T695C	SNP	695	695	T	1130	1130	C	609	C	524	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	7588	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3757	604.3	0	.	n	.	0	C1790T	SNP	1790	1790	C	2225	2225	T	705	T,C,G	447,160,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	7588	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3757	604.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2406	2406	C	717	C	624	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	7588	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3757	604.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2480	2480	A	748	A,G	636,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	7588	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3757	604.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3032	3032	C	683	C	565	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	27	738	folP	852	852	100.0	folP.l15.c4.ctg.1	1821	121.2	1	SNP	p	R228S	0	.	.	682	684	CGC	1145	1147	CGC	180;181;181	C;G;C	154;156;155	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1308	gyrA	2751	2751	99.75	gyrA.l6.c4.ctg.1	3773	104.0	0	.	p	.	0	V19I	NONSYN	55	57	GTC	570	572	ATC	108;108;108	A;T;C	87;87;89	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1308	gyrA	2751	2751	99.75	gyrA.l6.c4.ctg.1	3773	104.0	0	.	p	.	0	M250I	NONSYN	748	750	ATG	1263	1265	ATA	96;96;97	A;T;A	85;81;84	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1308	gyrA	2751	2751	99.75	gyrA.l6.c4.ctg.1	3773	104.0	0	.	p	.	0	S767N	NONSYN	2299	2301	AGC	2814	2816	AAC	136;134;135	A;A;C	120;119;121	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1308	gyrA	2751	2751	99.75	gyrA.l6.c4.ctg.1	3773	104.0	1	SNP	p	S91F	0	.	.	271	273	TCC	786	788	TCC	96;97;97	T;C;C	84;85;85	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1308	gyrA	2751	2751	99.75	gyrA.l6.c4.ctg.1	3773	104.0	1	SNP	p	D95N	0	.	.	283	285	GAC	798	800	GAC	101;101;102	G;A;C,G	89;87;89,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	1308	gyrA	2751	2751	99.75	gyrA.l6.c4.ctg.1	3773	104.0	1	SNP	p	D95G	0	.	.	283	285	GAC	798	800	GAC	101;101;102	G;A;C,G	89;87;89,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	576	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1711	100.6	0	.	p	.	0	D79N	NONSYN	235	237	GAT	778	780	AAT	166;166;165	A,G;A;T	148,1;145;146	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	576	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1711	100.6	1	SNP	p	G45D	0	.	.	133	135	GGC	676	678	GGC	164;164;162	G;G;C,T	140;139;138,1	mtrR.WHO_U_01459:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	450	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1276	105.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1322	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3326	118.9	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1669	1671	ATC	139;138;139	A;T;C	118;116;117	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1322	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3326	118.9	0	.	p	.	0	V421A	NONSYN	1261	1263	GTC	1780	1782	GCC	144;145;145	G;C;C	124;125;125	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1322	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3326	118.9	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1822	1824	GCA	152;151;155	G;C;A	127;125;127	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1322	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3326	118.9	0	.	p	.	0	I596V	NONSYN	1786	1788	ATT	2305	2307	GTT	164;164;163	G;T;T	144;145;143	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1322	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3326	118.9	1	SNP	p	D86N	0	.	.	256	258	GAC	775	777	GAC	158;156;158	G;A,G;C	131;127,1;134	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1322	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3326	118.9	1	SNP	p	S87R	0	.	.	259	261	AGT	778	780	AGT	155;155;155	A,C;G;T	130,1;134;130	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1322	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3326	118.9	1	SNP	p	S87I	0	.	.	259	261	AGT	778	780	AGT	155;155;155	A,C;G;T	130,1;134;130	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1322	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3326	118.9	1	SNP	p	S87W	0	.	.	259	261	AGT	778	780	AGT	155;155;155	A,C;G;T	130,1;134;130	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1322	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3326	118.9	1	SNP	p	S88P	0	.	.	262	264	TCC	781	783	TCC	153;152;153	T;C;C	130;131;133	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1178	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2976	118.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1685	1687	GGC	159;158;157	G;G;C	133;133;136	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.0.001	penA.0.001	1	1	27	1172	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2771	126.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1462	1464	GCA	157;156;156	G;C;A	137;134;133	penA.0.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.0.001	penA.0.001	1	1	27	1172	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2771	126.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1465	1467	ATC	156;155;157	A;T;C	136;134;135	penA.0.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.0.001	penA.0.001	1	1	27	1172	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2771	126.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1477	1479	GTG	158;159;158	G;T;G	141;140;139	penA.0.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.0.001	penA.0.001	1	1	27	1172	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2771	126.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1477	1479	GTG	158;159;158	G;T;G	141;140;139	penA.0.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.0.001	penA.0.001	1	1	27	1172	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2771	126.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1978	1980	ACC	156;157;157	A,C;C;C,T	139,2;139;142,1	penA.0.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.0.001	penA.0.001	1	1	27	1172	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2771	126.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2032	2034	GCG	174;173;174	G;C;G	144;132;132	penA.0.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.0.001	penA.0.001	1	1	27	1172	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2771	126.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2032	2034	GCG	174;173;174	G;C;G	144;132;132	penA.0.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.0.001	penA.0.001	1	1	27	1172	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2771	126.7	1	SNP	p	G542S	0	.	.	1624	1626	GGC	2155	2157	GGC	157;157;157	G,C;G;C	130,1;135;139	penA.0.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.0.001	penA.0.001	1	1	27	1172	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2771	126.7	1	SNP	p	G545S	0	.	.	1633	1635	GGC	2164	2166	GGC	155;155;153	G,C;G;C	129,1;133;135	penA.0.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.0.001	penA.0.001	1	1	27	1172	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2771	126.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2182	2184	CCG	155;156;152	C,G,T;C;G,T	128,1,1;131;126,1	penA.0.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1552	ponA	2397	2397	99.83	ponA.l15.c4.ctg.1	3369	138.0	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1800	1802	CTG	163;163;164	C;T;G	138;137;138	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	616	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2058	89.7	0	.	p	.	0	S22G	NONSYN	64	66	AGC	529	531	GGC	128;126;126	G;G;C	105;104;105	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	616	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2058	89.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	711	711	C	115	C	98	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	876	porB1a	984	984	98.37	porB1a.l15.c4.ctg.1	1815	142.4	0	.	p	.	0	A29V	NONSYN	85	87	GCC	580	582	GTC	171;171;172	G,A;T,G;C	132,1;133,1;134	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	876	porB1a	984	984	98.37	porB1a.l15.c4.ctg.1	1815	142.4	0	.	p	.	0	T50A	NONSYN	148	150	ACT	643	645	GCT	156;156;156	G;C;T	133;134;131	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	876	porB1a	984	984	98.37	porB1a.l15.c4.ctg.1	1815	142.4	0	.	p	.	0	K88L	NONSYN	262	264	AAA	757	759	CTC	161;160;163	C;T,G;C	136;135,1;140	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	876	porB1a	984	984	98.37	porB1a.l15.c4.ctg.1	1815	142.4	0	.	p	.	0	G92V	NONSYN	274	276	GGC	769	771	GTC	162;162;162	G;T;C	140;137;139	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	876	porB1a	984	984	98.37	porB1a.l15.c4.ctg.1	1815	142.4	0	.	p	.	0	S93N	NONSYN	277	279	AGC	772	774	AAC	162;161;161	A;A;C	141;139;137	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	876	porB1a	984	984	98.37	porB1a.l15.c4.ctg.1	1815	142.4	0	.	p	.	0	H111R	NONSYN	331	333	CAT	826	828	CGT	156;157;158	C;G;T	138;141;141	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	876	porB1a	984	984	98.37	porB1a.l15.c4.ctg.1	1815	142.4	0	.	p	.	0	N114S	NONSYN	340	342	AAC	835	837	AGC	158;158;158	A;G;C	143;136;139	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	876	porB1a	984	984	98.37	porB1a.l15.c4.ctg.1	1815	142.4	0	.	p	.	0	I115V	NONSYN	343	345	ATC	838	840	GTC	156;154;156	G;T;C	140;139;142	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	876	porB1a	984	984	98.37	porB1a.l15.c4.ctg.1	1815	142.4	0	.	p	.	0	D120G	NONSYN	358	360	GAC	853	855	GGC	157;158;157	G;G;C	141;138;139	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	876	porB1a	984	984	98.37	porB1a.l15.c4.ctg.1	1815	142.4	0	.	p	.	0	Y201F	NONSYN	601	603	TAC	1096	1098	TTC	200;201;199	T;T;C,A	167;166;168,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	876	porB1a	984	984	98.37	porB1a.l15.c4.ctg.1	1815	142.4	0	.	p	.	0	S236R	NONSYN	706	708	AGC	1201	1203	CGC	189;192;194	C;G;CAA,CA	176;179;178,1	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	3034	rpoB	4179	4179	99.93	rpoB.l15.c4.ctg.1	5177	175.7	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2140	2142	CAT	161;160;160	C;A;T	141;141;139	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	472	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1314	107.9	1	SNP	p	V57M	0	.	.	169	171	GTG	676	678	GTG	188;188;190	G,A;T;G	164,1;161;163	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
